Before you sell to, join or invest in TriAgenics, Inc
MentionFox check on TriAgenics, Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/triagenics-inc-form-d-25000001
Check TriAgenics, Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about TriAgenics, Inc?
Based on the record MentionFox holds for this company. No flag is not a clearance.
TriAgenics, Inc filed a Form D with the Securities and Exchange Commission on 2025-04-17.
TriAgenics, Inc filed a Form D notice of an exempt securities offering with the SEC on April 17, 2025. The filing reports $500K sold. Its industry group is Other Health Care. It names Leigh Colby (Executive Officer, Director), David Waston (Director), John Chopack (Director) (SEC Form D, April 17, 2025).
Is this your company?
Sell to companies like TriAgenics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns TriAgenics, Inc.
Free to see. No signup.
More on the people and the money behind TriAgenics, Inc, from the filings we hold.
Other Health Care raises by companies based in Oregon, filed within 90 days of this one, largest first.
Get an email when TriAgenics, Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when TriAgenics, Inc raises, hires or launches. No email unless you switch it on.
Watch TriAgenics, Inc →Get the full cited report on TriAgenics, Inc
What the filing shows about TriAgenics, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TriAgenics, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives TriAgenics, Inc's address as 525 Sw Umatilla Avenue, Suite 102, Redmond, OR 97756.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
TriAgenics, Inc is a registered filer with the SEC (CIK 1732710) and has filed since 2025-04-17. 1 filing is on record, the latest on 2025-04-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
TriAgenics, Inc's Form D of 2025-04-17 names Leigh Colby, David Waston, John Chopack and 3 more as its officers, directors or promoters.
Its new offerings report $500K sold across 1 offering, as its own filings state.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
Leigh Colby is named as Executive Officer and Director on the Form D that TriAgenics, Inc filed with the SEC on 17 April 2025, one of 6 people that filing names.
David Waston is named as Director on the Form D that TriAgenics, Inc filed with the SEC on 17 April 2025, one of 6 people that filing names.
John Chopack is named as Director on the Form D that TriAgenics, Inc filed with the SEC on 17 April 2025, one of 6 people that filing names.
Jeffrey Jacobs is named as Director on the Form D that TriAgenics, Inc filed with the SEC on 17 April 2025, one of 6 people that filing names.
David Thrower is named as Executive Officer and Director on the Form D that TriAgenics, Inc filed with the SEC on 17 April 2025, one of 6 people that filing names.
George Shahin is named as Director on the Form D that TriAgenics, Inc filed with the SEC on 17 April 2025, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2025-04-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about TriAgenics, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TriAgenics, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TriAgenics, Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist TriAgenics, IncYou get an alert in MentionFox the next time this company shows up.
If you're behind TriAgenics, Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for TriAgenics, Inc. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/triagenics-inc-form-d-25000001